11/12/2012

Cytomedix has obtained 510(k) clearance from the FDA to market the Angel platelet rich plasma technology, which is used to process small blood samples or mixtures of bone marrow aspirate and blood. The system is designed to allow the quick and safe preparation of concentrated plasma in clinical and point-of-care intraoperative environments.

Full Story:
BeckersSpine.com

Related Summaries